Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. Coli-derived asparaginase

Lisa Figueiredo, Peter D. Cole, Richard A. Drachtman

Research output: Contribution to journal › Review article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Asparaginase Erwinia chrysanthemi as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia who have developed hypersensitivity to E. Coli-derived asparaginase'. Together they form a unique fingerprint.

Medicine & Life Sciences